diagnosi
etiolog
agent
respiratori
viral
infect
reli
tradit
cultur
antigen
detect
pilot
conduct
evalu
compar
perform
characterist
rtpcr
electrospray
ioniz
mass
spectrometri
rtpcresim
platform
convent
virolog
method
identifi
multipl
clinic
relev
respiratori
virus
nasopharyng
aspir
rtpcresim
respiratori
viru
surveil
kit
design
detect
respiratori
syncyti
viru
influenza
b
parainfluenza
type
adenovirida
type
af
coronavirida
human
bocaviru
human
metapneumoviru
patient
attend
emerg
depart
respiratori
season
consent
excess
frozen
archiv
nasopharyng
aspir
analys
posit
convent
virolog
rtpcresim
among
six
sampl
multipl
viral
pathogen
detect
sensit
specif
assay
respect
addit
virus
identifi
convent
virolog
assay
detect
human
bocavirus
coronavirus
sampl
rtpcresim
result
disagre
convent
virolog
sent
analysi
third
method
use
commerci
rtpcrbase
assay
identifi
virus
detect
convent
virolog
procedur
time
first
result
rtpcresim
hour
rtpcresim
demonstr
capac
detect
respiratori
virus
identifi
unidentifi
convent
method
rapidli
accur
time
diagnosi
acut
viral
respiratori
tract
infect
rti
import
individu
patient
manag
decis
well
appropri
infect
control
remain
challeng
clinician
laboratorian
mahoni
mani
clinic
virolog
laboratori
still
reli
labour
intens
timeconsum
diagnost
algorithm
incorpor
antigen
culturebas
method
mahoni
molecular
diagnost
assay
hold
great
potenti
impact
infecti
diseas
diagnosi
clinic
manag
particularli
viral
infect
convent
method
ie
antigen
cultur
base
method
provid
time
highli
accur
result
ratcliff
et
al
mani
rapid
nucleic
acid
amplif
test
develop
identifi
individu
viru
liolio
et
al
util
molecular
diagnost
clinic
set
may
best
realiz
singl
system
diagnost
platform
simultan
detect
multipl
pathogen
liao
et
al
pabbaraju
et
al
raymond
et
al
wu
tang
electrospray
ioniz
mass
spectrometri
follow
broadrang
revers
transcriptionpcr
rtpcresim
one
singl
system
diagnost
platform
potenti
detect
rapidli
also
identifi
quantifi
multipl
pathogen
simultan
date
studi
rtpcremim
restrict
detect
individu
respiratori
bacteria
virus
ie
streptococcu
coronaviru
sar
adenoviru
russel
et
al
influenza
virus
sampath
et
al
detail
character
eg
resist
gene
recognit
genotyp
organ
capac
rtpcremim
broad
rang
simultan
multipl
pathogen
detect
rapid
turnaround
may
translat
use
tool
clinician
health
care
set
aid
earli
diagnosi
respiratori
tract
infect
hospitalbas
pilot
studi
conduct
one
season
respiratori
infect
compar
perform
characterist
rtpcresim
platform
versu
convent
virolog
procedur
identif
multipl
clinic
relev
respiratori
virus
nasopharyng
aspir
sampl
collect
emerg
depart
patient
present
acut
respiratori
ill
patient
visit
adult
paediatr
emerg
depart
tertiari
care
innerc
hospit
decemb
may
assess
elig
elig
patient
oper
defin
patient
suspect
acut
upper
respiratori
tract
infect
emerg
physician
order
nasopharyng
aspir
test
approach
consecut
recruit
elig
patient
identifi
dedic
studi
coordin
daili
review
nasopharyng
aspir
test
order
list
emerg
depart
sought
inform
consent
person
still
hospit
telephon
alreadi
discharg
either
emerg
depart
inpati
set
least
three
separ
attempt
differ
period
differ
day
attempt
contact
inform
consent
potenti
elig
subject
result
particip
rate
clinic
inform
obtain
chart
review
deriv
patient
demograph
variabl
hospit
relat
respiratori
tract
infect
episod
length
stay
hospit
day
admit
sampl
maintain
clinic
virolog
laboratori
frozen
standard
virolog
procedur
complet
part
standard
laboratori
protocol
studi
approv
john
hopkin
univers
institut
review
board
nasopharyng
aspir
test
ie
rapid
immunochromatograph
test
binax
inver
bedford
uk
influenza
virus
rsv
respiratori
season
direct
fluoresc
antibodi
test
ultra
dfa
respiratori
viru
id
kit
diagnost
hybrid
athen
oh
shell
vial
cultur
identif
rmix
diagnost
hybrid
athen
oh
adenoviru
influenza
virus
parainfluenza
virus
rsv
tube
cultur
adenoviru
influenza
virus
parainfluenza
virus
human
mpv
rsv
hsv
cmv
enteroviru
hemadsorpt
inhibit
test
process
accord
standard
algorithm
figur
clinic
virolog
laboratori
virolog
identif
routin
pcr
test
perform
clinic
virolog
laboratori
sampl
process
total
nucleic
acid
extract
use
thermo
kingfish
waltham
robot
accord
ambion
abi
foster
citi
ca
magmax
viral
kit
extract
protocol
pcr
reaction
well
amplifi
onestep
rtpcr
cycl
protocol
protocol
develop
support
rtpcr
convent
pcr
equal
primer
pair
use
rtpcr
perform
reaction
mix
consist
amplitaq
gold
appli
biosystem
foster
citi
ca
tri
ph
kcl
betain
mix
datp
dgtp
dctp
dttp
biolin
usa
inc
randolph
dithiothreitol
sonic
polya
dna
sigma
corp
st
loui
mo
random
hexam
invitrogen
corp
carlsbad
ca
superasin
ambion
corp
austin
tx
protein
roch
diagnost
corp
indianapoli
superscript
iii
invitrogen
corp
carlsbad
ca
sorbitol
sigma
corp
primer
follow
rtpcr
cycl
condit
use
min
follow
cycl
anneal
temperatur
increas
cycl
revers
transcript
pcr
continu
addit
cycl
rtpcr
cycl
end
final
extens
follow
hold
assay
perform
use
ibi
respiratori
viru
surveil
ii
kit
ibi
bioscienc
inc
carlsbad
ca
design
detect
subtyp
virus
seven
group
convent
virus
respiratori
syncyti
viru
rsv
influenza
b
parainfluenza
type
adenovirida
type
af
virus
identifi
convent
coronavirida
human
bocaviru
human
metapneumoviru
rtpcr
product
analys
use
ibi
univers
biosensor
platform
ibi
bioscienc
inc
carlsbad
ca
perform
autom
postpcr
desalt
esim
signal
acquisit
spectral
analysi
data
report
describ
previous
briefli
step
follow
pcr
reaction
desalt
purifi
use
weak
anion
exchang
protocol
describ
elsewher
jiang
hofstadl
accur
mass
highresolut
fwhm
mass
spectra
acquir
sampl
use
highthroughput
esim
protocol
sampath
et
al
sampl
approxim
analyt
solut
consum
spectral
acquisit
raw
mass
spectra
postcalibr
intern
mass
standard
deconvolv
monoisotop
molecular
mass
unambigu
base
composit
deriv
exact
mass
measur
complementari
singlestrand
oligonucleotid
detail
inform
softwar
use
interrog
amplicon
mass
virus
identif
describ
elsewher
calibr
consist
special
design
nucleic
acid
sequenc
similar
distinguish
potenti
sequenc
amplifi
well
intern
posit
control
neg
control
implement
batch
process
steril
viral
transport
media
clinic
virolog
laboratori
institut
perform
pcr
test
routin
respiratori
virus
accordingli
sampl
clinic
virolog
laboratori
rtpcresim
agre
suffici
volum
avail
sent
viracor
lee
summit
mo
identif
anoth
pcrbase
platform
luminex
respiratori
assay
austin
tx
design
detect
virus
rtpcr
esim
could
detect
except
human
bocaviru
pabbaraju
et
al
sampl
throughput
determin
rtpcresim
includ
use
one
kingfish
extract
robot
one
janu
autom
dispens
robot
four
eppendorf
thermocycl
simultan
one
cleanup
inject
autom
system
primari
analysi
evalu
perform
rtpcresim
convent
virolog
laboratori
result
use
refer
standard
figur
describ
number
subject
one
nasopharyng
aspir
sampl
evalu
also
includ
figur
number
evalu
result
oper
defin
purpos
primari
secondari
perform
evalu
number
individu
evalu
result
could
compar
one
anoth
sinc
nasopharyng
aspir
sampl
could
yield
test
result
cultur
rtpcrmsesi
neg
singl
posit
multipl
viral
detect
secondari
analysi
clinic
virolog
laboratori
result
secondari
ie
luminex
pcrbase
result
combin
refer
test
sampl
contain
virus
clinic
virolog
laboratori
protocol
avail
ie
bocaviru
coronaviru
detect
exclud
primari
analysi
includ
secondari
analysi
viral
agent
could
detect
luminex
rtpcrbase
method
ie
virus
except
bocaviru
confid
interv
sensit
specif
base
exact
binomi
probabl
subgroup
analysi
perform
detect
differ
perform
among
paediatr
adult
patient
decemb
june
patient
elig
recruit
among
consent
patient
younger
year
age
male
african
american
hospit
tabl
common
reason
patient
particip
studi
inabl
reach
subject
eg
wrong
telephon
number
registri
inabl
connect
telephon
call
median
storag
time
nasopharyng
aspir
month
rang
patient
evalu
result
primari
analysi
among
posit
detect
test
clinic
virolog
laboratori
found
shell
vial
cultur
follow
immunochromatograph
test
detect
influenza
virus
rsv
isol
viral
cultur
describ
bocavirus
exclud
specimen
bocaviru
bocaviru
detect
sampl
multipl
detect
well
coronaviru
sampl
primari
analysi
exclus
overal
agreement
rtpcresim
convent
virolog
ci
sensit
specif
ci
respect
tabl
sensit
rtpcresim
individu
pathogen
follow
parainfluenza
influenza
virus
rsv
adenoviru
tabl
rtpcresim
success
type
pathogen
includ
influenza
one
influenza
b
four
parainfluenza
type
one
adenoviru
type
match
find
clinic
virolog
six
adenoviru
type
c
adenoviru
clinic
virolog
laboratori
protocol
type
rtpcresi
ms
detect
multipl
viru
detect
sampl
tabl
total
evalu
result
figur
evalu
result
primari
analysi
find
rtpcresim
disagre
clinic
virolog
suffici
volum
togeth
coronaviru
posit
specimen
rtpcresim
protocol
clinic
virolog
laboratori
sent
evalu
secondari
pcrbase
method
luminex
total
sampl
twentyon
rtpcresim
result
confirm
luminex
includ
convent
virus
detect
influenza
rsv
adenoviru
coronaviru
detect
detect
convent
clinic
virolog
overal
agreement
sensit
specif
secondari
analysi
avail
sampl
respect
tabl
result
individu
pathogen
shown
tabl
accuraci
rtpcresim
differ
significantli
adult
paediatr
patient
time
first
result
sampl
prepar
detect
rtpcresim
hour
hour
dnarna
extract
hour
rtpcr
hour
process
esim
estim
throughput
rtpcresim
sampl
technician
work
hour
hospitalbas
pilot
studi
design
describ
preliminari
perform
novel
rtpcresim
platform
versu
current
diagnost
algorithm
use
clinic
virolog
laboratori
clinic
specimen
find
demonstr
assay
high
throughput
abl
detect
simultan
type
multipl
clinic
relev
respiratori
pathogen
nasopharyng
aspir
patient
suspect
viral
infect
accuraci
compar
convent
clinic
virolog
laboratori
test
studi
also
show
pathogen
detect
convent
clinic
virolog
method
could
detect
success
rtpcresim
platform
advantag
rtpcresim
platform
convent
test
includ
rapid
turnaround
capac
detect
multipl
respiratori
pathogen
simultan
high
throughput
provis
detail
pathogen
character
ie
semiquantit
type
subtyp
speci
commonli
use
diagnost
method
less
wellequip
clinic
virolog
laboratori
culturebas
may
take
day
yield
result
labourintens
costli
anzueto
niederman
although
rapid
antigen
test
offer
faster
detect
time
individu
pathogen
clinic
util
limit
pathogen
agent
usual
known
priori
test
suboptim
sensit
specif
ginocchio
demonstr
studi
rapid
antigen
test
detect
small
proport
influenza
rsv
clinic
specimen
suboptim
sensit
restrict
wider
util
rapid
test
clinic
set
compar
diagnost
algorithm
use
commonli
hospit
figur
rtpcresim
platform
provid
straightforward
approach
identif
clinic
relev
respiratori
virus
may
serv
diagnost
adjunct
ultim
data
demonstr
capac
rtpcresim
platform
type
subtyp
shown
come
pilot
studi
group
novel
influenza
virus
detect
confirm
addit
state
laboratori
test
use
center
diseas
control
prevent
novel
influenza
pcr
type
method
support
role
platform
surveil
clinic
public
health
set
gaydo
viral
load
quantit
capac
assay
detail
perform
separ
pilot
studi
group
demonstr
readout
viral
genom
copywel
rtpcresim
correl
posit
type
detect
method
employ
clinic
virolog
chen
method
evalu
perform
novel
assay
potenti
accur
current
refer
test
remain
controversi
research
employ
similar
assay
ie
secondari
pcr
base
assay
confirm
find
novel
assay
discord
convent
cultur
rapid
antigen
test
liolio
et
al
pabbaraju
et
al
other
propos
use
adjunct
clinic
data
refer
dore
unertl
heining
although
retrospect
studi
design
permit
detail
clinic
data
collect
refer
secondari
analysi
perform
use
secondari
pcr
assay
howev
secondari
pcr
assay
still
perfect
diagnos
everi
type
respiratori
viru
clinic
sampl
result
two
four
adenoviru
detect
luminex
assay
poor
sensit
detect
pabbaraju
et
al
abl
confirm
studi
may
underestim
perform
rtpcresim
platform
adenovirus
subgroup
analysi
differ
found
perform
characterist
platform
among
differ
clinic
subgroup
studi
popul
hypothes
could
due
small
sampl
size
pilot
howev
specimen
clinic
virolog
laboratori
neg
group
found
contain
significantli
lower
viral
load
rtpcresim
platform
compar
posit
group
data
present
could
explain
better
sensit
nucleic
acid
amplif
test
mahoni
studi
confirm
perform
among
patient
differ
demograph
characterist
merit
current
studi
sever
import
limit
although
optim
design
determin
whether
candid
assay
perform
potenti
better
gold
standard
third
confirmatori
test
done
everi
sampl
limit
volum
excess
nasopharyng
aspir
sampl
preclud
type
detail
evalu
accordingli
reader
caution
interpret
result
secondari
analysi
care
sinc
could
overestim
perform
assay
hadgu
dendukuri
hilden
reason
specimen
bocaviru
detect
rtpcresim
could
confirm
anoth
limit
rtpcresim
test
excess
nasopharyng
aspir
sampl
perform
sever
month
initi
clinic
sampl
obtain
test
clinic
virolog
although
effect
length
storag
nasopharyng
aspir
shown
minim
within
month
ward
et
al
anoth
studi
suggest
nucleic
acid
degrad
may
associ
storag
frisbi
et
al
impact
longer
period
storag
remain
unknown
furthermor
major
studi
popul
compris
paediatr
patient
year
age
limit
generaliz
find
adult
popul
futur
valid
perform
rtpcresim
platform
adult
popul
necessari
lastli
ibi
respiratori
viru
surveil
ii
kit
design
detect
rhinoviru
one
preval
respiratori
virus
howev
modifi
respiratori
viru
surveil
kit
develop
includ
rhinoviru
accuraci
reliabl
type
platform
merit
studi
use
prospect
clinic
respiratori
specimen
conclus
innov
rtpcresim
technolog
could
detect
virus
identifi
convent
virolog
method
rapidli
accur
allow
identif
mix
pathogen
clinic
specimen
detect
convent
virus
miss
clinic
virolog
algorithm
unconvent
virus
requir
addit
confirmatori
test
evalu
perform
characterist
assay
rtpcresim
method
promis
diagnost
platform
rapid
identif
convent
unconvent
virus
merit
prospect
evalu
refer
web
version
pubm
central
supplementari
materi
diagnost
algorithm
use
clinic
virolog
laboratori
detect
respiratori
virus
mainli
divid
respiratori
season
nonrespiratori
season
respiratori
season
defin
octob
follow
januari
octob
novemb
rsv
decemb
januari
influenza
immunochromatograph
assay
use
respiratori
season
sole
screen
test
rsv
influenza
stop
test
algorithm
result
posit
respiratori
panel
cocktail
dfa
test
serv
adenoviru
influenza
b
parainfluenza
type
rsv
stop
test
algorithm
result
posit
nonrespiratori
season
screen
neg
immunochromatograph
assay
respiratori
season
well
rsv
respiratori
syncyti
viru
piv
parainfluenza
viru
hsv
herp
simplex
viru
cmv
cytomegaloviru
hmpv
human
metapneumoviru
dfa
direct
fluoresc
antibodi
test
cpe
cytopath
effect
rbc
red
blood
cell
bocaviru
detect
clinic
virolog
laboratori
secondari
rtpcr
base
platform
exclud
subject
bocaviru
detect
bocaviru
detect
exclud
bocaviru
coronaviru
detect
clinic
virolog
laboratori
protocol
detect
includ
primari
perform
analysi
tabl
six
coronaviru
sampl
clinic
virolog
laboratori
rtpcresim
agre
suffici
volum
left
sent
secondari
rtpcr
base
assay
secondari
analysi
na
avail
one
coronaviru
isol
detect
convent
virolog
refer
test
adenoviru
exclud
one
coronaviru
detect
insuffici
volum
send
secondari
pcr
method
